AXT (NASDAQ:AXTI) Director Sells $664,081.24 in Stock

AXT Inc (NASDAQ:AXTI) Director Jesse Chen sold 6,133 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $108.28, for a total value of $664,081.24. Following the sale, the director directly owned 94,193 shares in the company, valued at approximately $10,199,218.04. This trade represents a 6.11% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Jesse Chen also recently made the following trade(s):

• On Wednesday, June 3rd, Jesse Chen sold 4,000 shares of AXT stock. The shares were sold at an average price of $111.36, for a total value of $445,440.00.
• On Friday, March 13th, Jesse Chen sold 8,083 shares of AXT stock. The shares were sold at an average price of $50.25, for a total value of $406,170.75.
• On Thursday, March 12th, Jesse Chen sold 6,003 shares of AXT stock. The shares were sold at an average price of $48.95, for a total value of $293,846.85.
• On Wednesday, March 11th, Jesse Chen sold 15,000 shares of AXT stock. The shares were sold at an average price of $47.13, for a total value of $706,950.00.
• On Tuesday, March 10th, Jesse Chen sold 14,000 shares of AXT stock. The shares were sold at an average price of $46.15, for a total value of $646,100.00.
• On Monday, March 9th, Jesse Chen sold 12,452 shares of AXT stock. The shares were sold at an average price of $37.69, for a total value of $469,315.88.

AXT Price Performance

NASDAQ:AXTI opened at $89.04 on Monday. The stock’s 50-day simple moving average is $89.22 and its 200 day simple moving average is $47.38. The firm has a market capitalization of $5.82 billion, a PE ratio of -287.22 and a beta of 1.80. AXT Inc has a twelve month low of $1.72 and a twelve month high of $143.16.

AXT (NASDAQ:AXTI) last released its quarterly earnings data on Thursday, April 30th. The semiconductor company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. The business had revenue of $26.92 million for the quarter, compared to analyst estimates of $26.22 million. AXT had a negative return on equity of 5.71% and a negative net margin of 14.69%.AXT has set its Q2 2026 guidance at 0.060-0.080 EPS. On average, analysts anticipate that AXT Inc will post 0.2 EPS for the current fiscal year.

Hedge Funds Weigh In On AXT

A number of hedge funds have recently made changes to their positions in AXTI. American Capital Advisory LLC bought a new position in shares of AXT during the first quarter worth about $27,000. Kohmann Bosshard Financial Services LLC bought a new position in shares of AXT during the first quarter worth about $31,000. XTX Topco Ltd bought a new position in shares of AXT during the second quarter worth about $42,000. Jefferies Financial Group Inc. bought a new position in shares of AXT during the third quarter worth about $52,000. Finally, Leonteq Securities AG bought a new position in shares of AXT during the first quarter worth about $57,000. 49.52% of the stock is currently owned by institutional investors.

AXT News Roundup

Here are the key news stories impacting AXT this week:

• Negative Sentiment: CEO Morris Young and Director Jesse Chen disclosed multiple stock sales over the past few days, including large transactions that trimmed their ownership stakes. Heavy insider selling can weigh on sentiment because it may signal that management views the shares as fully valued or prefers to reduce exposure at current levels. SEC filing for Jesse Chen sale
• Negative Sentiment: Traders bought 42,750 put options, about 58% above normal daily volume, suggesting a notable increase in bearish bets or hedging activity on AXT shares.
• Neutral Sentiment: Recent commentary highlighted AXT’s order backlog topping $100 million and management’s plan to double capacity in 2026 and again in 2027, reflecting strong AI-related demand for indium phosphide substrates. Article: AXT’s Order Backlog Surge & Capacity Push Fuel Growth Expectations
• Neutral Sentiment: The company’s latest earnings beat expectations modestly and Q2 guidance called for adjusted EPS of $0.06 to $0.08, but the business remains unprofitable on a net basis, which keeps the stock sensitive to execution and margin concerns.

Analysts Set New Price Targets

Several analysts recently weighed in on AXTI shares. UBS Group set a $35.00 price objective on AXT in a research note on Tuesday, February 17th. Northland Securities set a $125.00 price objective on AXT in a research note on Wednesday. Wedbush lifted their price target on AXT from $8.50 to $28.00 and gave the company an “outperform” rating in a research note on Friday, February 20th. Weiss Ratings raised AXT from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 27th. Finally, B. Riley Financial lifted their price target on AXT to $21.00 and gave the company a “neutral” rating in a research note on Friday, February 20th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, AXT currently has an average rating of “Hold” and an average target price of $43.80.

AXT Company Profile

AXT, Inc (NASDAQ: AXTI) is a global supplier of compound and single-element semiconductor substrates, offering a range of materials critical for high-performance electronic and optoelectronic devices. Founded in 1986 and headquartered in Fremont, California, AXT specializes in the development, manufacture and distribution of wafers composed of gallium arsenide (GaAs), indium phosphide (InP), gallium nitride (GaN) and other compound semiconductor materials. These substrates serve as the foundational platforms for devices used in data communications, wireless infrastructure, advanced computing, consumer electronics and photovoltaic applications.

AXT’s product portfolio encompasses a variety of wafer sizes, dopant concentrations and crystal orientations, tailored to meet the precise specifications of its customers.